Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1995-12-7
|
pubmed:abstractText |
We investigated the potential of corticotropin-releasing factor (CRF) to reduce neurogenic plasma extravasation in sensitised guinea pig airways evoked by antigen challenge. Inhalation of 5% ovalbumin for 2 min in the presence of phosphoramidon (2.5 mg/kg, i.v.) increased extravasation of Evans blue dye in the trachea and main bronchi. The increase in plasma extravasation induced by antigen challenge was significantly reduced by pretreatment with CRF (30 nmol/kg, i.v.) (73% in the trachea and 42% in the main bronchi). The inhibition of plasma extravasation by CRF (30 nmol/kg, i.v.) alone was not different from the inhibition induced by the combination of CRF and the tachykinin NK1 receptor antagonist, CP-99,994 (4 mg/kg, i.v.) (73% in the trachea and 38% in the main bronchi). CRF (30 nmol/kg, i.v.) inhibited by 32% in the trachea and by 43% in the main bronchi plasma extravasation induced by aerosolised bradykinin but did not reduce the plasma extravasation caused by aerosolised substance P in the presence of phosphoramidon. These findings suggest that CRF reduces ovalbumin-induced plasma extravasation in guinea pig airways by inhibiting the release of tachykinins from primary sensory nerves.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/3-(2-methoxybenzylamino)-2-phenylpip...,
http://linkedlifedata.com/resource/pubmed/chemical/Corticotropin-Releasing Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Glycopeptides,
http://linkedlifedata.com/resource/pubmed/chemical/Piperidines,
http://linkedlifedata.com/resource/pubmed/chemical/Protease Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Neurokinin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Substance P,
http://linkedlifedata.com/resource/pubmed/chemical/Tachykinins,
http://linkedlifedata.com/resource/pubmed/chemical/phosphoramidon
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0014-2999
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
4
|
pubmed:volume |
280
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
113-8
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:7589174-Animals,
pubmed-meshheading:7589174-Capillary Permeability,
pubmed-meshheading:7589174-Corticotropin-Releasing Hormone,
pubmed-meshheading:7589174-Glycopeptides,
pubmed-meshheading:7589174-Guinea Pigs,
pubmed-meshheading:7589174-Hemodynamics,
pubmed-meshheading:7589174-Male,
pubmed-meshheading:7589174-Piperidines,
pubmed-meshheading:7589174-Protease Inhibitors,
pubmed-meshheading:7589174-Receptors, Neurokinin-1,
pubmed-meshheading:7589174-Respiratory Physiological Phenomena,
pubmed-meshheading:7589174-Respiratory System,
pubmed-meshheading:7589174-Substance P,
pubmed-meshheading:7589174-Tachykinins
|
pubmed:year |
1995
|
pubmed:articleTitle |
Corticotropin-releasing factor inhibits antigen-induced plasma extravasation in airways.
|
pubmed:affiliation |
Cardiovascular Research Institute, University of California San Francisco 94143, USA.
|
pubmed:publicationType |
Journal Article,
In Vitro
|